Special reminder: As the Spring Festival approaches, the domestic veterinary drug raw material trading market has seen little change compared to last week due to the impact on the circulation market.
01 Chloramphenicol and tetracycline products showed a stable overall trend.
Fluoroquinolone, during the second week of February, saw a stable market price range of 155-165. Compared to the previous week, the price remained basically unchanged, with a year-on-year decrease of 13.5%. It is a product that Asia-Pacific Easy and Data Analysis Research Institute have focused on.
Thiamphenicol has a stable market situation with a market price of 175. The month-on-month decrease is 0.6%, and the year-on-year decrease is 12.5%. The average prices for the same period in the past three years from 2025 to 2023 were 196, 236, and 363 respectively. The market trend in February is stable.
Doxycycline hydrochloride, with a market price range of 304-319, has shown a stable trend in February.
Oxytetracycline, oxytetracycline hydrochloride. The market price range for oxytetracycline is 75-85; for oxytetracycline hydrochloride, it is 95-105, with a month-on-month decrease of 0.4% and a year-on-year increase of over 10%. The average prices for the same period in the past five years from 2025 to 2021 are 99, 94, 99, 102, and 108, respectively.
Chlortetracycline hydrochloride, with a market price range of 145-155, remained basically unchanged compared to last week's price, with a year-on-year decrease of 10.8%.
The overall operation of penicillin and cephalosporin products is stable.
Amoxicillin and amoxicillin sodium. Amoxicillin, with a market price range of 165-175, has seen a month-on-month decrease of 0.5% and a year-on-year decrease of over 20%; amoxicillin sodium, with a market price range of 300-355, has remained basically unchanged compared to last week's price, but has seen a year-on-year decrease of over 20%. The market trend in February is downward.
Overview of amoxicillin market data in 2025: The transaction price continued to decline in the first half of the year, with the decline reaching a three-year high. In the first quarter, the average price was 239 in January, dropped to 230 in February, fell below 220 in March, and saw a slight increase in April. In the second quarter, the average price was 216, with a decline of over 20% in the first half of the year. In the third quarter, the price fell below the 200-line mark in early July, then plummeted to 180, continued to decline to 160 in August, hitting a 60-month low, and bottomed out at the end of September. In the fourth quarter, the price maintained a downward trend, dropping to the 160-line mark in December and falling back to the price at the end of August. Bulk trading prices continued to "plummet".
Amoxicillin and clavulanate potassium, with a market price of 500, has seen a month-on-month decrease of 0.5%, and a year-on-year decrease of over 30%.
Overview of amoxicillin and clavulanate potassium market data in 2025: The first quarter saw a stable trend with an average price of 776. The second quarter saw a gradual decline with small fluctuations, with market transaction prices ranging from 770 to 700. The second half of the year saw a significant decline, with a decrease of over 20%, and the fourth quarter saw an average price of 537. The annual price per kilogram fell by nearly 300 yuan. Ampicillin showed a stable market trend, with a market price of 175, a month-on-month decrease of 1.3%, and a year-on-year decrease of over 20%. The market trend in January was stable.
Ampicillin, with a market price range of 169-179, saw a month-on-month decrease of 1.3% and a year-on-year decrease of over 20%. The market trend in February was stable.
Overview of ampicillin 2025 market data: The annual decline exceeded 25%. The market experienced small fluctuations in the first half of the year, with prices ranging from 255 to 235. In the third quarter, prices fell below the 200-line mark, averaging at 190. In the fourth quarter, prices broke through the 180 mark.
Ampicillin sodium, with a relatively weak performance, has a market price ranging from 275 to 315, with a month-on-month decrease of 0.6% and a year-on-year decrease of 16.5%.
Penicillin sodium, with a market price range of 100-115/billion, has seen a month-on-month decrease of 0.3% and a year-on-year decrease of over 30%. The market trend in February is downward.
Penicillin potassium industrial salt, with a market price range of 60-70 per billion.
Ceftiofur sodium, cefotiofur hydrochloride, and ceftiofur sodium for injection, with different levels of sterility and non-sterility, have a wide price range. Ceftiofur sodium, with a relatively weak performance, has a price range of 830-930, with a month-on-month decrease of 0.9% and a year-on-year decrease of nearly 20%. Cefotiofur hydrochloride has a market price of 800-910, with a month-on-month decrease of 0.8% and a year-on-year decrease of 15.7%. Ceftiofur sodium for injection has a market price of 3600-4300, which is basically the same as last week's price, with a year-on-year decrease of 14.1%. The average prices for the same period in the past five years from 2025 to 2021 are 4950, 5600, 6350, 6900, and 6500, respectively.
All rights reserved by Asia-Pacific Easy and Data Analysis Research Institute for original articles. The market data analysis refers to the comprehensive price of bulk products and should not be used as a basis for investment.
The overall performance of aminoglycoside products was relatively weak.
Neomycin sulfate, with a market price of around 155/billion, has seen a month-on-month decrease of 0.4% and a year-on-year decrease of 3.7%. The current market is in the phase of destocking, with increasing downward pressure. The average prices from 2025 to February 2023 were 160, 130, and 150 respectively.
Spectinomycin dihydrochloride (sulfate) has seen an easing of supply, with a market price of 555. The month-on-month decrease is 1.3%, while the year-on-year increase exceeds 20%. Transaction prices vary significantly across different regions and brands, and the market trend in February was relatively weak.
Streptomycin sulfate has a stable market situation, with a price range of 265-305/billion.
Amprolium sulfate, with a market price of 199, remained unchanged compared to last week's price, showing a year-on-year decrease of 7.1%. The average prices for February 2025, 2026, and 2023 were 214, 217, and 200 respectively, indicating a relatively strong market trend in February.
Kanamycin monosulfate, with a market transaction price of 295/billion, saw a month-on-month decrease of 0.3%. Compared to last year, the price remained basically unchanged, indicating a stable market trend in February.
Amikacin sulfate, with a market price of 745, saw a month-on-month decrease of 0.8% and a year-on-year drop of over 10%. The market trend in February remained stable.
Gentamicin sulfate, with a market price of 1050-1150/billion, remains basically unchanged compared to last week's market, but has decreased by nearly 20% year on year.
Macrolides and other antibiotics such as tartaric acid tylosin, with a market price of around 275, have seen a slight decrease compared to last week's market situation, but an increase of over 20% year-on-year. The average prices for the same period in 2025, 2023, and 2022 were 218, 245, and 292 respectively. Asia-Pacific Easy and Data Analysis Research Institute focuses on this product.
Tilmicosin and tilmicosin phosphate. Tilmicosin, with a market price of 350, has a month-on-month decrease of 0.7%, while its year-on-year increase exceeds 20%; tilmicosin phosphate, with a market price of around 305, has a month-on-month decrease of 1.3%, while its year-on-year increase is 25.9%. There is a large bargaining space for bulk trading prices.
Tartaric acid kitasamycin, market price 350.
Tylvalosin Tartrate, with a market price of 390, has seen a month-on-month decrease of 2.3% and a year-on-year increase of 6.1%. The market trend in February is downward.
Tylosin, market price 8000.
Erythromycin thiocyanate, with a market transaction price of 480, has experienced a month-on-month decrease of 2.1% and a year-on-year decrease of 4.5%.
Colistin sulfate, market price 113.
Tylosin fumarate, with a market price of 255, remains basically unchanged compared to last week's price, but has increased by over 10% year-on-year.
Lincomycin hydrochloride has a stable market situation, with a market price of 322 yuan/billion, a month-on-month decrease of 0.5%, and a decrease of nearly 100 yuan per billion compared to the same period last year.
Original article from Asia-Pacific Easy and Data Analysis Research Institute. Reproduction without permission is prohibited. Any infringement will be prosecuted. For reproduction and quotation, please contact the author and indicate the original source.
05 Quinolones: Quinolones market is experiencing low volatility.
Enrofloxacin and enrofloxacin hydrochloride. The current market price is 168, with a year-on-year decrease of over 10%. The market situation in February is mainly stable.
Ciprofloxacin lactate (hydrochloride), priced at 160, has a stable market trend, with a year-on-year decrease of 10.6%. The average prices from 2025 to February 2023 were 176, 188, and 212 respectively.
Salafloxacin hydrochloride has a stable market situation, with a current market price of 400.
Mapofloxacin, with a market price of 2370, has seen a month-on-month decrease of 0.9% and a year-on-year decrease of 15.1%.
The overall market trend of sulfa products is stable.
Sulfamethoxazole (sodium) has a trading price range of 180-239, with average prices of 206, 209, and 295 for the years 2025, 2023, and February 2023, respectively.
The current market price of sulfamethoxazole (sodium) is around 245.
Sulfamethoxazole (sodium) has a stable market situation, with a price range of 105-145. It has decreased by 0.5% month-on-month and increased by 3.1% year-on-year.
Sulfadiazine (sodium) is currently quoted at 150 in the market, with the average prices for the same period in 2025, 2023 being 162, 175, and 205 respectively.
Sulfamethazine (sodium) has maintained a stable market situation, with a market price of 99. Compared to last week, the price remains basically unchanged, and the year-on-year increase is 24.4%. The average prices for the same period in 2025, 2022, and 2023 were 82, 85, and 100, respectively.
Sulfamethoxazole sodium, with a current market price of 195, is basically unchanged compared to last week's price, but has increased by more than 20% year-on-year. The average prices from 2025 to February 2023 were 165, 180, and 310 respectively.
Sulfamethoxazole and pyrimethamine sodium, with a market price of 215, had average prices of 218, 234, and 315 in February 2023, 2024, and 2025, respectively.
Sulfachloropyridazine sodium, with a market price of 179, remained basically unchanged compared to last week's price, with a year-on-year increase of 2.3%. The average prices from 2025 to February 2023 were 175, 147, and 165 respectively.
"Dimethoprim, stable trend, market price 380.".
Trimethoprim, trimethoprim lactate. Trimethoprim, market price 238; trimethoprim lactate, market price 188.
07 Anti-parasitic drug Albendazole, with relatively strong performance, has a market price of 135, with a month-on-month increase of 0.5% and a year-on-year decrease of over 10%.
Fenbendazole, with relatively strong performance, has a market price of 230, with a month-on-month increase of 1.1% and a year-on-year decrease of 11.6%.
Avermectin, trading price 530-600.
Ivermectin, with a relatively weak performance, has a market price of 750. The average prices for the same period in the past five years from 2025 to 2021 were 760, 918, 1130, 1520, and 1280 respectively.
Dikouzhuili, market price 970.
Toltrazuril, market price 830.
Levamisole hydrochloride is performing relatively strongly, with a market price of 360, a month-on-month increase of 0.3%, and a year-on-year increase of over 10%.
Amprolium hydrochloride, with relatively strong performance, has a market price of 335.
Metronidazole, with a market price of 79, has average prices of 79, 80, and 88 for the same period from 2025 to 2023.
Demetridazole, with a market price of 99, had average prices of 88, 114, and 119 during the same period from 2025 to 2023.
Praziquantel, with a market price of 295, has seen a month-on-month decrease of 0.3%, and a year-on-year decrease of over 10%.
Cyromazine, with a relatively weak operational performance, has a market price of 108.
To learn more, please join the Asia-Pacific Easy and Data Analysis Research Institute as a member to stay updated on market changes in real time.
The overall trend of antipyretic and analgesic products, which are used for relieving fever, asthma, and enhancing immunity, remains stable.
Flunixin meglumine has a stable market situation, with a market price of 370 yuan, a month-on-month decrease of 0.4%, and a year-on-year decrease of over 10%.
Analgin, with a market price of around 80.
Acetaminophen, market price 23.
Aminopyrine, market price 100.
Aminophylline, market price 115.
Aspirin, with a market price of 19,300/ton.
Taurine, with its market price on the rise, is currently trading at 17,500/ton, marking a month-on-month increase of 1.5% and a year-on-year increase of 13.7%. The corresponding tonnage prices for the same period from 2025 to 2023 were 14,600, 17,200, and 24,300, respectively.
Carbasalate calcium, with a transaction price of around 29, has had average prices of 34, 35, and 36 in February for the past three years, from 2025 to 2023.
Overview of market data for antipyretic analgesic, antiasthmatic, and immunity-enhancing products in 2025: Market prices for different varieties exhibit a significant trend of differentiation. According to the market data from Yihe Data Analysis Research Institute in Asia-Pacific, they can be divided into three categories: First, flunixin meglumine is generally on a downward trend; second, the market trends for acetaminophen, aminophylline, and aminopyrine are relatively stable; third, varieties such as metamizole, carbasalate calcium, aspirin, and taurine exhibit more significant price fluctuations.
The market for analgin was mainly stable in the first quarter, with an average price of 87. After mid-June in the second quarter, there was a significant decline, with the price falling below 80 in August. In the third quarter, the average price was 78, and in the fourth quarter, there was a rebound at the end of October, with prices ranging from 75 to 85.
Carbasalate calcium started at 35 in the first quarter, began to rise to a high of 45 at the end of February, gradually declined after May in the second quarter, fell sharply in June, gradually declined in the third and fourth quarters, and accelerated its decline in December, with all brands falling below the 30-line.
Aspirin experienced a rapid rise in the first half of the year, increasing from 19,800/ton in January to 27,500/ton in April, and gradually rebounding to 21,200/ton in the second half. The annual fluctuation was significant, which may be related to changes in raw material costs and inventory adjustments. Taurine's average price in the first half of the year was 12,200/ton, surpassing 13,000/ton in the third quarter, and recovering to over 14,500/ton in the fourth quarter. Its fluctuations may be associated with seasonal demand, inventory changes in the industrial chain, and investment-related factors.
09 Veterinary drug excipients and other types of acetyl-mequindox, trading range 40-50, with market consolidation and volatility.
Sodium camphor sulfonate, market price 55, with fluctuating market conditions.
Chlorpheniramine, with a market price of 150, saw a month-on-month increase of 1.3% and a year-on-year decrease of 14.3%. The market trend in January was relatively strong.
Sodium salicylate, with a rising market, is traded at a price of 25,900/ton.
Citric acid saw a market rise in February, with the market price reaching 4500/ton.
Sodium citrate saw a market price increase in February, with the market price reaching 4650/ton.
Sodium carbonate, with a market price of 2200/ton.
Sodium bicarbonate, with a market price of 2500/ton.
Glucose, trading price: 3960-6200/ton.
Jiayi powder, trading price 2710-3200/ton.
Soluble starch, market price 12900/ton.
Beta-cyclodextrin, with a market price of 19,000/ton.
The overall trend of plant-based traditional Chinese medicinal materials products remains stable.
Shuanghuanglian extract, 50-80.
Astragalus Polysaccharide Extract, 60-110.
Scutellaria baicalensis extract, 110-140.
Licorice extract, 60-95.
Honeysuckle extract, 75-135.
Honeysuckle, 50-100.
Huanglian, 240-290.
Astragalus, 7-12.
Scutellaria, 22-29.
Yanhusuo, 55-65.
Chenpi, 10-13.
Hawthorn, 8-12.
Licorice, 19-30.
Dried ginger, 16-25.
Safflower, 62-80.
Banlangen, 18-29.
11 Vitamin A, low-level operation, mixing ratio 60-65, water solubility 80.
VB1, market stable, nitric acid 235, hydrochloric acid 290.
VB2, 98% purity priced at 270, 80% purity priced at 70.
VB6, with a stable market, has a market price of 112.
VB12 1%, market price around 90, stable market situation.
VC, the market quotation is around 20 for feed grade and 28 for pharmaceutical grade.
VD3, market price for mixing is 140, water solubility is 160, showing a downward trend.
VE, mixing material 60, water solubility 99.
VK3, market price 70, downward trend in February.
Calcium pantothenate, stable operation, market price 42.
Nicotinamide, stable operation, market price 40.
Biotin 2%, market price 30.
Folic acid, market price 380.
The above is the analysis of the domestic veterinary drug raw material market data for the fifth week of 2026, released by the Asia-Pacific Easy and Data Analysis Research Institute. Please review and correct it.
